Bicocca Open Archive

Logo unimib boa
POZZI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.657
AS - Asia 9.189
EU - Europa 5.816
SA - Sud America 1.034
AF - Africa 196
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 9
Totale 26.943
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.356
SG - Singapore 2.710
VN - Vietnam 2.455
CN - Cina 1.780
IT - Italia 1.474
DE - Germania 969
HK - Hong Kong 904
RU - Federazione Russa 858
BR - Brasile 786
SE - Svezia 552
GB - Regno Unito 388
IE - Irlanda 357
FR - Francia 258
IN - India 255
KR - Corea 216
CA - Canada 195
FI - Finlandia 177
ID - Indonesia 136
AT - Austria 133
BD - Bangladesh 124
NL - Olanda 101
UA - Ucraina 101
JP - Giappone 100
AR - Argentina 95
TR - Turchia 91
IQ - Iraq 83
LT - Lituania 75
DK - Danimarca 74
ES - Italia 73
MX - Messico 61
PL - Polonia 55
ZA - Sudafrica 52
CH - Svizzera 51
PK - Pakistan 51
SA - Arabia Saudita 44
AU - Australia 39
EG - Egitto 39
BE - Belgio 36
EC - Ecuador 36
MY - Malesia 32
CO - Colombia 31
PH - Filippine 31
VE - Venezuela 27
PY - Paraguay 22
TW - Taiwan 22
RO - Romania 20
MA - Marocco 19
TH - Thailandia 18
AE - Emirati Arabi Uniti 16
ET - Etiopia 16
IR - Iran 16
UZ - Uzbekistan 16
CL - Cile 14
CZ - Repubblica Ceca 13
KZ - Kazakistan 13
DZ - Algeria 12
JO - Giordania 12
OM - Oman 12
IL - Israele 11
TN - Tunisia 11
KE - Kenya 10
BO - Bolivia 9
HN - Honduras 8
UY - Uruguay 8
AO - Angola 7
CR - Costa Rica 7
EU - Europa 7
PS - Palestinian Territory 7
RS - Serbia 7
AZ - Azerbaigian 6
BG - Bulgaria 6
HR - Croazia 6
NG - Nigeria 6
NI - Nicaragua 6
NP - Nepal 6
PA - Panama 5
PE - Perù 5
AL - Albania 4
BN - Brunei Darussalam 4
GR - Grecia 4
HU - Ungheria 4
JM - Giamaica 4
KG - Kirghizistan 4
LV - Lettonia 4
SN - Senegal 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
LY - Libia 3
MD - Moldavia 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CU - Cuba 2
GE - Georgia 2
Totale 26.913
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.752
Singapore 1.627
Dallas 1.511
Ashburn 923
Hong Kong 870
San Jose 778
Ho Chi Minh City 743
Hanoi 591
Milan 575
Frankfurt am Main 572
Wilmington 345
Dublin 344
Chandler 329
Los Angeles 324
New York 314
Beijing 253
Dearborn 229
Santa Clara 209
Hefei 195
Chicago 186
Seoul 178
Munich 165
Houston 154
Woodbridge 152
Princeton 134
The Dalles 133
Fairfield 130
Nanjing 119
Helsinki 116
Vienna 110
Jakarta 101
Council Bluffs 95
Buffalo 94
Lauterbourg 94
Moscow 91
Shanghai 91
Seattle 85
Da Nang 81
Orem 81
São Paulo 79
Guangzhou 76
Jacksonville 73
Toronto 73
Boardman 69
Haiphong 64
Tokyo 60
Vilnius 58
Ha Long 56
Hải Dương 53
Basingstoke 50
Chennai 50
Rome 50
Dong Ket 49
Denver 47
London 46
Biên Hòa 45
Baghdad 44
Amsterdam 43
Warsaw 43
Montreal 42
Carate Brianza 38
Zurich 38
Ninh Bình 36
Pune 36
Atlanta 35
Bắc Ninh 35
Can Tho 35
Nuremberg 35
Rio de Janeiro 35
Quận Bình Thạnh 34
Brooklyn 33
Poplar 33
Kent 31
Stockholm 31
Lawrence 30
Nanchang 30
Shenyang 30
Vũng Tàu 30
Cambridge 29
Altamura 28
Phoenix 28
Hangzhou 27
Melzo 27
Turku 26
Manchester 25
Mexico City 25
Thái Nguyên 25
Bắc Giang 23
Brussels 22
Johannesburg 22
San Francisco 22
Falls Church 21
Florence 21
Lappeenranta 21
Ottawa 21
Shangdi 21
Quận Một 20
Tianjin 20
Zhengzhou 20
Paris 19
Totale 17.162
Salva come PNG Salva come JPEG
Nome #
CIPN and its mechanism of development 596
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 576
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 501
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 447
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 443
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 441
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 425
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 420
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 417
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 414
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 404
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 394
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 386
OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY IN MOUSE MODELS: DIFFERENT TREATMENT SCHEDULES AND FOCUS ON OXIDATIVE STRESS 385
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 380
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 373
Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity 370
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 369
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 355
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 354
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 340
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 338
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 331
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 328
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 315
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 310
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 309
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 306
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 300
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 300
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 298
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 297
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 296
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 294
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 293
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 290
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 290
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 285
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 282
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 282
In vivo study of Carfilzomib-Induced Neuropathy 277
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 273
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 273
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 269
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 267
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 264
Multimodal experimental approach to the study of human neurological diseases 260
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 260
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 257
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 255
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 255
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 255
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 244
Genetic factors influencing the development of vincristine-induced neurotoxicity 244
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 240
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 238
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 238
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 237
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 237
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 233
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 227
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 223
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 222
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 217
Oxaliplatin neurotoxicity: morpho-functional approach 215
Metabolomics assessment in a mice model ofoxaliplatin-induced peripheral neurotoxicity 215
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 215
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 212
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 212
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 211
The relevance of morphology in experimental oxaliplatin-induced peripheral neurotoxicity 209
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 208
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 208
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 208
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 206
High resolution MRI in exploring peripheral nerve anatomy and axonal damage in rodent models 203
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 203
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 203
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 201
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 192
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 192
INVESTIGATION OF AGING EFFECTS ON NERVE DAMAGE IN AN ANIMAL MODEL OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY 191
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 188
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 181
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 175
REFINEMENT OF MORPHOLOGICAL ANALYSIS OF THE CAUDAL NERVE IN A RODENT MODEL OF AXONAL DAMAGE WITH 7T MRI 171
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN) 165
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 165
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 164
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 163
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 158
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 153
Oxaliplatin-Induced Peripheral Neurotoxicity: a Role for Genomics? 152
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 149
Can different Mice Strains be differently susceptible to Oxaliplatin-Induced Peripheral Neuropathy? 137
Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity 134
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 134
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 125
Investigation of Supraspinal Plasticity of Painful Paclitaxel-Induced Peripheral Neuropathy 124
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 118
Totale 26.959
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021374 0 0 0 0 0 0 0 0 0 0 140 234
2021/20221.106 111 133 110 97 93 104 49 49 44 52 79 185
2022/20231.884 187 371 239 174 166 306 63 75 136 41 82 44
2023/20241.561 69 61 73 92 156 358 246 104 77 39 47 239
2024/20255.197 241 501 470 235 403 283 438 187 578 711 408 742
2025/202613.506 2.210 1.469 1.978 1.301 1.171 673 1.729 647 989 1.104 235 0
Totale 27.873